Hou Jiabao, Lu Mingjun, Guo Jingwei, Wu Jinghong, Wang Chenyang, Zhou Ping-Kun, Ma Teng
Cancer Research Center, Beijing Chest Hospital, Beijing Tuberculosis and Thoracic Tumor Research Institute, Capital Medical University, Beijing, 101149, China.
Beijing Key Laboratory for Radiobiology Beijing Institute of Radiation Medicine, Beijing, 100850, China.
Cell Mol Biol Lett. 2025 Mar 4;30(1):25. doi: 10.1186/s11658-025-00703-z.
The DNA-dependent protein kinase catalytic subunit (DNA-PKcs) is a key kinase in the DNA repair process that responds to DNA damage caused by various factors and maintains genomic stability. However, DNA-PKcs is overexpressed in some solid tumors and is frequently associated with poor prognosis. DNA-PKcs was initially identified as a part of the transcription complex. In recent years, many studies have focused on its nonclassical functions, including transcriptional regulation, metabolism, innate immunity, and inflammatory response. Given the pleiotropic roles of DNA-PKcs in tumors, pharmacological inhibition of DNA-PK can exert antitumor effects and may serve as a potential target for tumor therapy in the future. This review summarizes several aspects of DNA-PKcs regulation of RNA metabolism, including its impact on transcriptional machinery, alternative splicing, and interaction with noncoding RNAs, and provides insights into DNA-PKcs beyond its DNA damage repair function.
DNA依赖性蛋白激酶催化亚基(DNA-PKcs)是DNA修复过程中的关键激酶,它对各种因素引起的DNA损伤作出反应并维持基因组稳定性。然而,DNA-PKcs在一些实体瘤中过度表达,且常与预后不良相关。DNA-PKcs最初被鉴定为转录复合物的一部分。近年来,许多研究聚焦于其非经典功能,包括转录调控、代谢、固有免疫和炎症反应。鉴于DNA-PKcs在肿瘤中的多效性作用,对DNA-PK的药理学抑制可发挥抗肿瘤作用,未来可能成为肿瘤治疗的潜在靶点。本综述总结了DNA-PKcs对RNA代谢调控的几个方面,包括其对转录机制、可变剪接以及与非编码RNA相互作用的影响,并对DNA-PKcs超出其DNA损伤修复功能的方面提供了见解。